Susceptibilities of human cytomegalovirus clinical isolates to BAY38-4766, BAY43-9695, and ganciclovir

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 10, 2001, Pages 2925-2927

  McSharry, J J ^a   McDonough, A ^a   Olson, B ^a   Hallenberger, S ^a   Reefschlaeger, J ^a   Bender, W ^a   Drusano, G L ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BAY43 9695; GANCICLOVIR; TOMEGLOVIR; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG POTENCY; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; GANCICLOVIR; HUMANS; MICROBIAL SENSITIVITY TESTS; NAPHTHALENESULFONATES; VIRUS REPLICATION;

EID: 0034810929     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.10.2925-2927.2001     Document Type: Article

References (17)

1. Cytomegalovirus
2. Ganciclovir
3. Resistance of human cytomegalovirus to antiviral drugs
4. Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis
5. Cytomegalovirus retinitis and viral resistance: Ganciclovir resistance
6. Nonnucleoside pyrrolopyrimidines with a unique mechanism of action against human cytomegalovirus
7. Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading flames: UL89 and UL56
8. Antiviral drug susceptibility assays: Going with the flow
9. Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates
10. Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates
11. Recent advances in the therapy and prevention of CMV infections
12. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS
13. Infections in solid-organ transplant recipients
14. Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria
15. Ganciclovir-resistant cytomegalovirus clinical isolates: Mode of resistance to ganciclovir
16. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product
17. Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo